Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Derosa

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Vaccine|February 1, 2022
Pan-SARS neutralizing responses after third boost vaccination in non-human primate immunogenicity modelKirill V Kalnin, Timothy Plitnik, Michael Kishko, et al.
NPJ Vaccines|December 17, 2021
Development of multivalent mRNA vaccine candidates for seasonal or pandemic influenzaSudha Chivukula, Timothy Plitnik, Timothy Tibbitts, et al.
NPJ Vaccines|April 20, 2021
Immunogenicity and efficacy of mRNA COVID-19 vaccine MRT5500 in preclinical animal modelsKirill V Kalnin, Timothy Plitnik, Michael Kishko, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Vaccine|February 1, 2022
Pan-SARS neutralizing responses after third boost vaccination in non-human primate immunogenicity modelKirill V Kalnin, Timothy Plitnik, Michael Kishko, et al.
NPJ Vaccines|December 17, 2021
Development of multivalent mRNA vaccine candidates for seasonal or pandemic influenzaSudha Chivukula, Timothy Plitnik, Timothy Tibbitts, et al.
NPJ Vaccines|April 20, 2021
Immunogenicity and efficacy of mRNA COVID-19 vaccine MRT5500 in preclinical animal modelsKirill V Kalnin, Timothy Plitnik, Michael Kishko, et al.
Pageof 4